Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire

Sponsor

Gazi University (Other)

Overall Status

Recruiting

CT.gov ID

NCT04736641

Collaborator

(none)

105

Enrollment

Location

Anticipated Duration (Months)

5.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ).

Condition or Disease	Intervention/Treatment	Phase
Hip Disease Hip Pain Chronic	Other: Survey study

Detailed Description

There are a number of medical assessment tools for various diseases, but in most cases such tools are designed to reflect the perspective of healthcare providers, not perspective of patients. In addition to clinical results, it is necessary to evaluate the quality of life of patients when measuring the effect of medical treatments. Thus, evaluation criteria which can be useful as patient-reported outcome indices, have received increasing attention in recent years. Health-related quality of life provides a patient-reported assessment. Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) evaluates quality of life related to hip disorders. It is also a guide in determining the expectations of individuals in the treatment process. It consists of 3 subscales (pain, movement and mental) and 20 items. Hip condition and pain are evaluated with a 100 mm scale. 20 items are scaled likert with values between 0 and 4. "0" means "strongly agree", "1" means "agree", "2" means "uncertain", "3" means "disagree" and "4" means "strongly disagree". The study is planned with 105 individuals with hip disease. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in JOAHDEQ, Oxford Hip Score, International Hip Outcome Tool-12, Short Form-36, and Visual Analog Scale Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.

Study Design

Study Type:

Observational

Anticipated Enrollment :

105 participants

Observational Model:

Other

Time Perspective:

Prospective

Official Title:

Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire

Actual Study Start Date :

Mar 1, 2021

Anticipated Primary Completion Date :

Sep 1, 2022

Anticipated Study Completion Date :

Sep 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Patients group Individuals with hip disease and chronic pain on hip	Other: Survey study Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) will be applied

Arm

Intervention/Treatment

Patients group

Individuals with hip disease and chronic pain on hip

Other: Survey study

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) will be applied

Outcome Measures

Primary Outcome Measures

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) [15 minutes]
Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire is designed to evaluate quality of life related to hip disorders.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 70 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Any diagnosed hip disease,
Chronic hip pain,
History of pain when lying or during weight-bearing activities, aggravated by activity for more than 3 months.

Exclusion Criteria:

Lumbar spine nerve root findings,
History of lumbar spine or hip surgery,
Corticosteroid injection to hip in the past 3 months.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Halime ARIKAN	Ankara	None Selected	Turkey	06490

Sponsors and Collaborators

Gazi University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Halime ARIKAN, Research Assistant, Gazi University

ClinicalTrials.gov Identifier:

NCT04736641

Other Study ID Numbers:

26.01.2021-E.13996

First Posted:

Feb 3, 2021

Last Update Posted:

May 4, 2021

Last Verified:

May 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Halime ARIKAN, Research Assistant, Gazi University

Hip disease

Reliability

Validity

Cross-cultural adaptation

Study Results

No Results Posted as of May 4, 2021